Charles Schwab Investment Management Inc. Reduces Stake in Avanos Medical, Inc. (NYSE:AVNS)

Charles Schwab Investment Management Inc. lessened its stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 7.9% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 523,494 shares of the company's stock after selling 44,734 shares during the quarter. Charles Schwab Investment Management Inc. owned 1.14% of Avanos Medical worth $12,580,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of the stock. Quest Partners LLC purchased a new stake in shares of Avanos Medical during the 2nd quarter worth about $444,000. Deerfield Management Company L.P. Series C purchased a new position in Avanos Medical during the second quarter worth approximately $551,000. Janney Montgomery Scott LLC grew its holdings in Avanos Medical by 194.3% in the third quarter. Janney Montgomery Scott LLC now owns 35,918 shares of the company's stock valued at $863,000 after purchasing an additional 23,714 shares during the period. AQR Capital Management LLC increased its position in shares of Avanos Medical by 21.0% in the second quarter. AQR Capital Management LLC now owns 146,983 shares of the company's stock valued at $2,875,000 after buying an additional 25,467 shares in the last quarter. Finally, Intech Investment Management LLC acquired a new position in shares of Avanos Medical during the 3rd quarter worth approximately $207,000. Hedge funds and other institutional investors own 95.17% of the company's stock.

Avanos Medical Price Performance

Shares of NYSE:AVNS traded up $0.07 during trading on Monday, reaching $18.54. The stock had a trading volume of 200,440 shares, compared to its average volume of 244,414. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. Avanos Medical, Inc. has a 1-year low of $17.39 and a 1-year high of $25.36. The stock has a market cap of $852.10 million, a PE ratio of 54.32 and a beta of 0.95. The business has a fifty day moving average price of $20.77 and a 200-day moving average price of $21.49.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut shares of Avanos Medical from a "strong-buy" rating to a "buy" rating in a research note on Sunday, November 3rd.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.